Cargando…
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087993/ https://www.ncbi.nlm.nih.gov/pubmed/37057104 http://dx.doi.org/10.21037/tlcr-23-117 |
| _version_ | 1785022475484004352 |
|---|---|
| author | Hydbring, Per |
| author_facet | Hydbring, Per |
| author_sort | Hydbring, Per |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10087993 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100879932023-04-12 Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients Hydbring, Per Transl Lung Cancer Res Editorial AME Publishing Company 2023-03-17 2023-03-31 /pmc/articles/PMC10087993/ /pubmed/37057104 http://dx.doi.org/10.21037/tlcr-23-117 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Hydbring, Per Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title | Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title_full | Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title_fullStr | Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title_full_unstemmed | Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title_short | Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients |
| title_sort | plasma-derived immune-related factors as biomarkers of osimertinib resistance in egfr-mutant non-small cell lung cancer patients |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087993/ https://www.ncbi.nlm.nih.gov/pubmed/37057104 http://dx.doi.org/10.21037/tlcr-23-117 |
| work_keys_str_mv | AT hydbringper plasmaderivedimmunerelatedfactorsasbiomarkersofosimertinibresistanceinegfrmutantnonsmallcelllungcancerpatients |